Eli Lilly and Company (NYSE: LLY) reported revenue of $7.9 billion for the fourth quarter of 2021, up 8% year-over-year. Reported net income decreased 18% to $1.72 billion, or $1.90 per share, compared to last year. Adjusted net income increased 8% to $2.2 billion while adjusted EPS rose 8% to $2.49. For the full year […]
Eli Lilly and Company (NYSE: LLY) reported revenue of $7.9 billion for the fourth quarter of 2021, up 8% year-over-year. Reported net income decreased 18% to $1.72 billion, or $1.90 per share, compared to last year. Adjusted net income increased 8% to $2.2 billion while adjusted EPS rose 8% to $2.49. For the full year […]
Eli Lilly and Company (NYSE: LLY) reported revenue of $7.9 billion for the fourth quarter of 2021, up 8% year-over-year.
Reported net income decreased 18% to $1.72 billion, or $1.90 per share, compared to last year.
Adjusted net income increased 8% to $2.2 billion while adjusted EPS rose 8% to $2.49.
For the full year of 2021, adjusted EPS is estimated to be $8.50-8.65.
